Pacer Advisors »

Lexeo Therapeutics shares owned by Pacer Advisors

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Pacer Advisors from 13F filings

Historical chart of Pacer Advisors investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Pacer Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Pacer Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.0k 1.1k 4.43

More positions owned by Pacer Advisors

NVIDIA Corp Common Stock - Domestic (NVDA)
Bristol-Myers Squibb Common Stock - Domestic (BMY)
Altria Group Common Stock - Domestic (MO)
Comcast Corp Common Stock - Domestic (CMCSA)
Apple Common Stock - Domestic (AAPL)
Booking Holdings Common Stock - Domestic (BKNG)
Verizon Communications Common Stock - Domestic (VZ)
Pfizer Common Stock - Domestic (PFE)
At&t Common Stock - Domestic (T)
Qualcomm Common Stock - Domestic (QCOM)
Gilead Sciences Common Stock - Domestic (GILD)
HCA Healthcare Common Stock - Domestic (HCA)
Lowe's Cos Common Stock - Domestic (LOW)
Uber Technologies Common Stock - Domestic (UBER)
Newmont Corp Common Stock - Domestic (NEM)

View all positions for Pacer Advisors

Top funds holding Lexeo Therapeutics

Suvretta Capital Management
Affinity Asset Advisors
BlackRock
RA Capital Management
Henderson Group
Frazier Life Sciences Management
Vestal Point Capital
Paradigm Biocapital Advisors
Jupiter Topco
OrbiMed Advisors
Citadel Advisors
State Street Corporation
Vanguard Capital Management
Millennium Management
Woodline Partners

View all funds holding Lexeo Therapeutics